ovarian cancer

• UPDATE 2-Zeltia jumps on ovarian cancer drug news | Markets | Markets News |…
  Zeltia estimates that in the European Union alone peak sales of Yondelis for the treatment of ovarian cancer would be around 300 million euros a year, which Chapman said was around five years away.Europe…